CDC Issues Guidance on COVID-19 Rebound After Paxlovid Treatment
Paxlovid (nirmatrelvir tablets co-packaged with ritonavir tablets) continues to be recommended for early stage treatment of mild to moderate COVID-19…
Paxlovid (nirmatrelvir tablets co-packaged with ritonavir tablets) continues to be recommended for early stage treatment of mild to moderate COVID-19…
Home » Specialties » Womens Health The Food and Drug Administration (FDA) has authorized for emergency use the Labcorp Seasonal…
Post-COVID lung disease includes 3 different subtypes or subgroups that potentially require separate and different management, according to a study…
Treatment with interleukin-6 (IL-6) inhibitors decreased the risk of death among patients with COVID-19 infection by 75% compared with standard…
The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the InspectIR COVID-19 Breathalyzer, the first…
The risk of immediate allergic reactions or anaphylaxis after a second dose of the SARS-CoV-2 mRNA vaccine is low in…
The Food and Drug Administration (FDA) has scheduled a virtual meeting of its Vaccines and Related Biological Products Advisory Committee…
COVID-19 encourages nightmare activity, according to new research from Nature and Science of Sleep. Patients with COVID-19 have experienced increased…
Rates of skin infections have risen dramatically in recent decades and continue to exacerbate burdens already experienced by many resource-constrained…
Among the various cardiovascular sequalae associated with COVID-19, an increase in the number of cases of stress cardiomyopathy – also…